Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Government Agencies›
Matec
AddedFeb 16, 2024
UpdatedJun 18, 2026
Matec

Matec

Operating

Publicly funded Midwest center offering HIV/AIDS clinical training for healthcare professionals.

Founded
1988
Location
Chicago, IL, US
Overview
Compare
Employees
Website

Matec, the Midwest AIDS Training and Education Center, is dedicated to developing and transforming the healthcare system to advance equitable and patient-centered care. The organization focuses on providing HIV/AIDS clinical training and support to healthcare professionals, offering evidence-based, unbiased, and innovative learning opportunities. Matec's mission encompasses strengthening advocacy efforts to sustain and grow programmatic resources.

As a publicly funded training center, Matec plays a crucial role in enhancing the skills and knowledge of healthcare workers in the Midwest region. The organization's commitment to health equity and maximum health for all is reflected in its diverse projects and training programs. Matec's local offices ensure widespread access to its resources and support across the Midwest.

Matec - Similar Organizations

Central Nine Career Center logo

Central Nine Career Center

central9.k12.in.us

Johns Hopkins University School of Medicine logo

Johns Hopkins University School of Medicine

Hennepin Healthcare System logo

Hennepin Healthcare System

Matec - Quick Facts

What organizations are similar to Matec?

Organizations similar to Matec include Central Nine Career Center, Johns Hopkins University School of Medicine and Hennepin Healthcare System.

When was Matec founded?

Matec was founded in 1988.

Where is Matec's headquarters located?

Matec's headquarters is located in Chicago, IL, US.

When was Matec's last funding round?

Matec's most recent funding round was for $3M (USD) in October 2022.

How much has Matec raised to-date?

As of Oct 26, 2022, Matec has raised a total of $3M (USD).

How many employees does Matec have?

Matec has 75 employees as of Feb 4, 2024.

Matec - Classification

Ownership
  • Government
Technology
  • HealthTech
Revenue
  • Recurring
Main Product
  • Clinical Training
Tags
  • Non-profit
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified